BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34049974)

  • 1. A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC.
    Gopalan V; Singh A; Rashidi Mehrabadi F; Wang L; Ruppin E; Arda HE; Hannenhalli S
    Cancer Res; 2021 Aug; 81(15):3958-3970. PubMed ID: 34049974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset.
    Xu Y; Nipper MH; Dominguez AA; Ye Z; Akanuma N; Lopez K; Deng JJ; Arenas D; Sanchez A; Sharkey FE; Court CM; Singhi AD; Wang H; Fernandez-Zapico ME; Sun LZ; Zheng S; Chen Y; Liu J; Wang P
    Nat Commun; 2024 Jan; 15(1):818. PubMed ID: 38280869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
    Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
    Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma.
    Tekin C; Scicluna BP; Lodestijn SC; Shi K; Bijlsma MF; Spek CA
    Mol Oncol; 2021 Nov; 15(11):3091-3108. PubMed ID: 33932087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer.
    Kalisz M; Bernardo E; Beucher A; Maestro MA; Del Pozo N; Millán I; Haeberle L; Schlensog M; Safi SA; Knoefel WT; Grau V; de Vas M; Shpargel KB; Vaquero E; Magnuson T; Ortega S; Esposito I; Real FX; Ferrer J
    EMBO J; 2020 May; 39(9):e102808. PubMed ID: 32154941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment.
    Jakubison BL; Schweickert PG; Moser SE; Yang Y; Gao H; Scully K; Itkin-Ansari P; Liu Y; Konieczny SF
    Mol Oncol; 2018 Jun; 12(7):1104-1124. PubMed ID: 29719936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
    Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
    Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.
    Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL
    Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
    Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
    Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell of origin affects tumour development and phenotype in pancreatic ductal adenocarcinoma.
    Lee AYL; Dubois CL; Sarai K; Zarei S; Schaeffer DF; Sander M; Kopp JL
    Gut; 2019 Mar; 68(3):487-498. PubMed ID: 29363536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBPJ Deficiency Sensitizes Pancreatic Acinar Cells to KRAS-Mediated Pancreatic Intraepithelial Neoplasia Initiation.
    Pan L; Mulaw MA; Gout J; Guo M; Zarrin H; Schwarz P; Baumann B; Seufferlein T; Wagner M; Oswald F
    Cell Mol Gastroenterol Hepatol; 2023; 16(5):783-807. PubMed ID: 37543088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male Mice.
    Young CC; Baker RM; Howlett CJ; Hryciw T; Herman JE; Higgs D; Gibbons R; Crawford H; Brown A; Pin CL
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):93-113. PubMed ID: 30510993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANGPTL4 accelerates KRAS
    Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS
    Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice.
    Johnson BL; d'Alincourt Salazar M; Mackenzie-Dyck S; D'Apuzzo M; Shih HP; Manuel ER; Diamond DJ
    PLoS One; 2019; 14(9):e0221810. PubMed ID: 31490946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
    Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
    Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of protein kinase Cδ leads to increased pancreatic acinar cell dedifferentiation in the absence of MIST1.
    Johnson CL; Peat JM; Volante SN; Wang R; McLean CA; Pin CL
    J Pathol; 2012 Nov; 228(3):351-65. PubMed ID: 22374815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic fibrosis, acinar atrophy and chronic inflammation in surgical specimens associated with survival in patients with resectable pancreatic ductal adenocarcinoma.
    Korpela T; Ristimäki A; Udd M; Vuorela T; Mustonen H; Haglund C; Kylänpää L; Seppänen H
    BMC Cancer; 2022 Jan; 22(1):23. PubMed ID: 34980011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis.
    Jiang Z; Wu F; Laise P; Takayuki T; Na F; Kim W; Kobayashi H; Chang W; Takahashi R; Valenti G; Sunagawa M; White RA; Macchini M; Renz BW; Middelhoff M; Hayakawa Y; Dubeykovskaya ZA; Tan X; Chu TH; Nagar K; Tailor Y; Belin BR; Anand A; Asfaha S; Finlayson MO; Iuga AC; Califano A; Wang TC
    Cell Stem Cell; 2023 Aug; 30(8):1091-1109.e7. PubMed ID: 37541213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids.
    Huang L; Desai R; Conrad DN; Leite NC; Akshinthala D; Lim CM; Gonzalez R; Muthuswamy LB; Gartner Z; Muthuswamy SK
    Cell Stem Cell; 2021 Jun; 28(6):1090-1104.e6. PubMed ID: 33915081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.